Kidney and urological involvement in Down syndrome: frequent, underestimated, but associated with impaired quality of life and risk of kidney failure
- PMID: 37386331
- DOI: 10.1007/s00467-023-05986-y
Kidney and urological involvement in Down syndrome: frequent, underestimated, but associated with impaired quality of life and risk of kidney failure
Abstract
Patients with Down syndrome (DS) are at risk of multiorgan dysfunction; kidney and urological impairment are common. This is due to a likely increased risk of congenital kidney and urological malformations (odds ratio of 4.5 compared to the general population in one study), more frequent associated comorbidities at risk of kidney dysfunction (such as prematurity in 9-24% of children, intrauterine growth retardation or low birth weight in 20%, and congenital heart disease in 44%), and more frequent lower urinary tract dysfunction (reported in 27-77% of children with DS). If present, malformations and comorbidities at risk of kidney dysfunction warrant regular kidney monitoring in addition to their treatment. Serum creatinine in children with DS has been shown to be higher than in the general population and asymptomatic hyperuricemia is reported in 12-33% of children or young adults with DS. Moreover cryptorchidism and testicular cancer are also more common and should be detected by clinical examination. Thus, persons with DS at risk of presenting kidney and urological impairment should be identified by prenatal ultrasonography, comorbidities at risk of kidney sequelae considered, and during regular medical follow-up, clinically examined and questioned to diagnose testicular anomalies and lower urinary tract dysfunction. This is of importance as such kidney and urological impairments are associated with impaired quality of life and mental health, and risk of kidney failure.
Keywords: Congenital malformation; Down syndrome; Kidney; Lower urinary tract dysfunction; Urological.
© 2023. The Author(s), under exclusive licence to International Pediatric Nephrology Association.
References
-
- Bull MJ (2020) Down Syndrome. N Engl J Med 382:2344–2352. https://doi.org/10.1056/NEJMra1706537 - DOI - PubMed
-
- Bull MJ, Trotter T, Santoro SL et al (2022) Health Supervision for Children and Adolescents With Down Syndrome. Pediatrics 149:e2022057010. https://doi.org/10.1542/peds.2022-057010 - DOI - PubMed
-
- Lagan N, Huggard D, Mc Grane F et al (2020) Multiorgan involvement and management in children with Down syndrome. Acta Paediatr 109:1096–1111. https://doi.org/10.1111/apa.15153 - DOI - PubMed
-
- Morris JK, Garne E, Wellesley D et al (2014) Major congenital anomalies in babies born with Down syndrome: A EUROCAT population-based registry study. Am J Med Genet A 164:2979–2986. https://doi.org/10.1002/ajmg.a.36780 - DOI
-
- Stoll C, Dott B, Alembik Y, Roth M-P (2015) Associated congenital anomalies among cases with Down syndrome. Eur J Med Genet 58:674–680. https://doi.org/10.1016/j.ejmg.2015.11.003 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical